Identidade

N-Nitroso Indapamide

Não indicado · C16H15ClN4O4S

01Identidade

Lazychem IDLC-21966
CAS RNNão indicado
PubChem CID176479250
Molecular formulaC16H15ClN4O4S
Molecular weight394.83 g/mol
IUPAC name(R)-4-chloro-N-(2-methylindolin-1-yl)-N-nitroso-3-sulfamoylbenzamide
InChIKeyKTFPGFAHNVOOMX-SNVBAGLBSA-N

02Estrutura e estereoquímica

2D structurePubChem CID 176479250
Two-dimensional chemical structure of N-Nitroso Indapamide
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 3 rings, includes aromatic atoms, includes aliphatic carbon, has 1 defined stereocentre, contains at least one halogen atom, contains an N-nitroso substructure. These statements are calculated from the published structure string.

Defined stereocentres1
Ring count3
Secondary amines0
Tertiary amines1
SMILESC[C@@H]1CC2=CC=CC=C2N1N(C(=O)C3=CC(=C(C=C3)Cl)S(=O)(=O)N)N=O
InChINão indicado

03Stereochemistry

The published structure contains 1 defined and 0 unassigned tetrahedral stereocentre. The exact wedge and dash depiction is shown above.

Defined centres1Structure assigned
Unassigned centres0Structure unspecified
Assignment statusFully assignedExact published identity
Tetrahedral upper bound≤ 2Before symmetry reduction

Published same-connectivity configurations

1 record

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

No additional structure-linked configuration with the same connectivity is currently present in the LazyChem dataset.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Estado na Índia

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Nomes e relações

API e fármaco de origem

Indapamide

Impurezas e compostos relacionados

Nomes e relações

    Impurezas e compostos relacionados

    06Fontes